Ioan Valentin Matei, M.D., Ph.D.
During his postdoctoral years, he worked at the Center for Gene and Cellular Therapies in the Treatment of Cancer OncoGen Timisoara, and then as part of the Dia-Cure project at Titu Maiorescu University’s Acad. N. Cajal Institute of Medical Research and Fundeni Clinical Institue’s Center of Excellence in Translational Medicine, coordinated by Prof. Sarah Ferber of Sheba Medical Center at Tel Hashomer and The Sackler School of Medicine at Tel Aviv University, studying the modulation of diabetic liver-to-pancreas transdifferentiation.
Ioan developed an interest in ageing research and synthetic biology, and is currently a member of the Systems Biology of Aging Group led by Dr. Robi Tacutu, working with Dr. Simona Ghenea on CRISPR-based gene editing for corroborating models of synergistic gene interaction generated through bioinformatic modeling for regulating longevity in Caenorhabditis elegans.
- . Hydrogen sulfide enhances pancreatic β-cell differentiation from human tooth under normal and glucotoxic conditions. Regenerative medicine, 2017, 12(2):125-141.IF=2.99
- . Contributions of evolutionary biology to the understanding of cancer. Proceedings of the Romanian Academy Series B, 2012, 3(14):183-190.
- . Correlations of visfatin with the lipidic metabolism in diabetic and obese patients. Proceedings of the Romanian Academy Series B, 2012, 1(14):37-43.
- . A cytomorphometric analysis of adipocytes from the omental and abdominal subcutaneous adipose tissue. Proceedings of the Romanian Academy Series B, 2011, 3(13):212-236.
Starting 02.09.2016, the Institute of Biochemistry of the Romanian Academy is implementing the project “Multi-omics prediction system for prioritization of gerontological interventions”, co-funded through European Fund for Regional Development, in accordance with the funding contract signed by the Ministry of National Education and Scientific Research. The total funding for the project is 8.524.757,50 lei, of which 8.502.557,50 lei represent non-reimbursable funding. The project’s duration is 48 months.
The project aims to experimentally develop an integrated and automated solution for screening drugs and genetic interventions for neurodegenerative diseases, using the nematode C. elegans and ageing-related data.